Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
药物滥用障碍、丙型肝炎病毒和艾滋病毒治疗的健康经济学:评估个人、系统和社区的干预结果
基本信息
- 批准号:10597210
- 负责人:
- 金额:$ 159万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAreaAwardCaringClinicalCommunicationCommunitiesConsultationsDataData LinkagesData SetDevelopmentEconomicsEducational CurriculumEnsureEvaluationEvaluation MethodologyEvaluation ResearchFunding OpportunitiesGrantHIVHIV/HCVHealthHealth behaviorHealth systemHealthcareHepatitis C virusIndividualInfrastructureInstitutionIntegrated Health Care SystemsInterventionKnowledgeLeadLeadershipLinkMassachusettsMentorsMentorshipMethodologyMethodsModelingOutcomeOutcomes ResearchParticipantPersonsPoliciesPolicy MakerPopulationProviderRecordsResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesScienceScientific Advances and AccomplishmentsServicesStructureSubstance Use DisorderSystemTrainingTraining ActivityTranslatingTreatment outcomeWorkadaptive interventionadvanced simulationcomparative effectiveness studydesigndissemination scienceeconomic evaluationexperiencehealth care service utilizationhealth economicsimplementation interventionimplementation researchimplementation studyimprovedinterestknowledge baseknowledge translationmembermodels and simulationnovel strategiesprogramssubstance usesubstance use treatmentsymposiumtooltranslational approach
项目摘要
OVERALL PROJECT SUMMARY
In the 4.5 years since our initial award, we have established CHERISH (Center for Health Economics of
Treatment Interventions for Substance Use Disorder, HCV, and HIV) as a National Center of Excellence for
health economic research related to substance use disorder policy and HCV and HIV care of people who use
substances. Our unique multi-institutional center leverages outstanding researchers with synergistic areas of
expertise. In the initial award period, our aims have focused on addressing the needs of integrated healthcare
system payers and providers. CHERISH guidance and input has resulted in addition of critical economic
components to comparative effectiveness studies that evaluate treatments delivered to individual participants
in healthcare or SUD treatment settings, including those evaluating interventions delivered at the health-
system or organization level. In this renewal period, we propose to expand our focus to add economic
components, develop economic methodologies, and improve knowledge translation strategies for health
outcome and implementation research that is conducted at the individual, system, and community levels.
Our proposal, entitled: “Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating
Intervention Outcomes for Individuals, Systems, and Communities,” has the overall aim to develop and
disseminate health economic research on healthcare utilization, health outcomes, and health-related
behaviors that informs substance use disorder treatment policy and HCV and HIV care of people who use
substances. The Center includes 3 Research Support Cores (Methodology Core, Population Data & Modeling
Core, and Dissemination & Policy Core), a Pilot Grant & Training Core that serves as the Pilot Research Project
Core, and an Administrative Core. The Methodology Core will continue its highly successful Consultation
Service and will develop new methods related to economic evaluation in implementation studies and adaptive
interventions. The new Population Data & Modeling Core will draw on recent experience of Core members in
Massachusetts to promote new approaches to state data linkages for population-level economic evaluations,
and will support a research consortium that advances simulation modeling methods for these populations. The
Dissemination & Policy Core will continue to engage in dissemination science activities that directly assist
research teams and further the science, continue to hold bi-annual stakeholder conferences, and develop a new
knowledge dissemination curriculum. The Pilot Grant & Training Core will continue to use experts from the
other Cores and Research Affiliates to select, evaluate, and mentor competitive pilot grant awardees, will
conduct new training and mentorship activities, and will lead a diversity initiative for the Center. The
Administrative Core will continue to provide infrastructure and leadership to all Cores.
总体项目摘要
自首次奖励以来的4。5年中,我们建立了珍惜(卫生经济中心
用于药物使用障碍,HCV和HIV的治疗干预措施是国家卓越中心
与药物使用障碍政策有关的健康经济研究以及使用的人的HCV和HIV护理
物质。我们独特的多机构中心利用具有协同领域的杰出研究人员
专业知识。在最初的奖励期内,我们的目标致力于满足综合医疗保健的需求
系统付款人和提供商。除了关键的经济外,还导致了珍贵的指导和意见
比较有效性研究的组成部分,评估交付给个人参与者的治疗方法
在医疗保健或SUD治疗环境中,包括评估在健康中提供的干预措施的情况
系统或组织级别。在这个续签时期,我们建议扩大我们的重点以增加经济
组件,开发经济方法并改善健康知识翻译策略
在个人,系统和社区层面进行的结果和实施研究。
我们的建议,题为:“药物使用障碍,HCV和HIV治疗的健康经济学:评估
对个人,系统和社区的干预结果“具有发展和发展的总体目标
传播有关医疗保健利用,健康结果和与健康有关的健康经济研究
为使用使用障碍障碍治疗政策的行为以及使用的人的HCV和艾滋病毒护理
物质。该中心包括3个研究支持核心(方法论核心,人口数据和建模)
核心,传播与政策核心),这是试点赠款和培训核心,作为试点研究项目
核心和行政核心。方法核心将继续其非常成功的咨询
服务并将开发与实施研究和适应性经济评估有关的新方法
干预措施。新的人群数据和建模核心将利用核心成员的最新经验
马萨诸塞州促进新的方法来实现人口级经济评估的数据联系,
并将支持一个研究联盟,该联盟推进了这些人群的模拟建模方法。这
传播与政策核心将继续从事直接协助的传播科学活动
研究团队和进一步的科学,继续举行两年一次的利益相关者会议,并开发新的
知识传播课程。飞行员赠款和培训核心将继续使用
其他核心和研究分支机构选择,评估和精神竞争性试点赠款授予者,将
进行新的培训和心态活动,并将领导该中心的多样性倡议。
行政核心将继续为所有核心提供基础设施和领导力。
项目成果
期刊论文数量(132)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Keep It Up! 3.0: Study protocol for a type III hybrid implementation-effectiveness cluster-randomized trial.
继续努力吧!
- DOI:10.1016/j.cct.2023.107134
- 发表时间:2023
- 期刊:
- 影响因子:2.2
- 作者:Mustanski,Brian;Saber,Rana;Jones,JustinPatrick;Macapagal,Kathryn;Benbow,Nanette;Li,DennisH;Brown,CHendricks;Janulis,Patrick;Smith,JustinD;Marsh,Elizabeth;Schackman,BruceR;Linas,BenjaminP;Madkins,Krystal;Swann,Gregory;Dean
- 通讯作者:Dean
Are decreases in drug use risk associated with reductions in HIV sex risk behaviors among adults in an urban hospital primary care setting?
城市医院初级保健机构中成年人吸毒风险的降低是否与艾滋病毒性风险行为的减少相关?
- DOI:10.1016/j.pmedr.2016.08.001
- 发表时间:2016
- 期刊:
- 影响因子:2.8
- 作者:Walter,AngelaWangari;Cheng,DebbieM;Lloyd-Travaglini,ChristineA;Samet,JeffreyH;Bernstein,Judith;Saitz,Richard
- 通讯作者:Saitz,Richard
Ending HIV in the United States Will Require a Substantial Financial Commitment.
在美国消灭艾滋病毒需要大量的财政承诺。
- DOI:10.7326/m21-3607
- 发表时间:2021
- 期刊:
- 影响因子:39.2
- 作者:Linas,BenjaminP
- 通讯作者:Linas,BenjaminP
Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths.
制定一项协议,确定旨在减少阿片类药物过量死亡的一套综合循证实践的成本。
- DOI:10.1097/adm.0000000000001218
- 发表时间:2024
- 期刊:
- 影响因子:5.5
- 作者:Tin,Yjuliana;Castry,Mathieu;Bowers-Sword,Rachel;Shantharam,Shruti;Aldridge,Arnie;Zarkin,GaryA;Starbird,Laura;Linas,BenjaminP;Barocas,JoshuaA;Morgan,JakeR
- 通讯作者:Morgan,JakeR
Costs of opioid overdose education and naloxone distribution in New York City.
- DOI:10.1080/08897077.2021.1986877
- 发表时间:2022
- 期刊:
- 影响因子:3.5
- 作者:Behrends, Czarina N.;Gutkind, Sarah;Winkelstein, Emily;Wright, Monique;Dolatshahi, Jennifer;Welch, Alice;Paone, Denise;Kunins, Hillary V.;Schackman, Bruce R.
- 通讯作者:Schackman, Bruce R.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce R Schackman其他文献
Bruce R Schackman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce R Schackman', 18)}}的其他基金
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学
- 批准号:
9506377 - 财政年份:2017
- 资助金额:
$ 159万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
物质使用障碍、HCV 和 HIV 治疗的健康经济学:评估个人、系统和社区的干预结果
- 批准号:
10208836 - 财政年份:2015
- 资助金额:
$ 159万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学
- 批准号:
9793440 - 财政年份:2015
- 资助金额:
$ 159万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学
- 批准号:
9110938 - 财政年份:2015
- 资助金额:
$ 159万 - 项目类别:
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorder
患有或不患有创伤后应激障碍的个人在与阿片类药物使用障碍 (OUD) 治疗提供者合作后利用医疗服务
- 批准号:
10355194 - 财政年份:2015
- 资助金额:
$ 159万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 159万 - 项目类别:
Advancing Student Potential for Inclusion with Research Experiences (ASPIRE)
通过研究经验提升学生融入的潜力(ASPIRE)
- 批准号:
10678356 - 财政年份:2023
- 资助金额:
$ 159万 - 项目类别:
Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
- 批准号:
10682983 - 财政年份:2023
- 资助金额:
$ 159万 - 项目类别:
Society of Ears, Nose, and Throat Advances in Children (SENTAC)
儿童耳鼻喉协会 (SENTAC)
- 批准号:
10683579 - 财政年份:2023
- 资助金额:
$ 159万 - 项目类别: